CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
GW Pharmaceuticals PLC- ADR Company Snapshot
GW Pharmaceuticals PLC- ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC- ADR with three other companies in this sector in the United States: Voyager Therapeutics Inc (2016 sales of $14.22 million ), Pharmaxis Ltd ($13.50 million of which 80% was Bronchitol and Aridol), and Cytomx Therapeutics Inc ($15.04 million of which 100% was Pharmaceutical).

Sales Analysis. Sales fell dramatically in 2016: GW Pharmaceuticals PLC- ADR reported sales of $14.57 million for the fiscal year ending September of 2016. This represents a sharp decrease of 66.9% versus 2015, when the company's sales were $43.99 million. Contributing to the drop in overall sales was the 85.6% decline in Sativex R&d, from $34.34 million to $4.94 million. There were also decreases in sales in Pipeline R&d (down 42.3% to $476,036.09 ) . However, these declines were partially offset by the increase in sales of Commercial (up 3.6% to $9.15 million) .
   
   
 
  Stock Performance Chart for GW Pharmaceuticals PLC- ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (8/18/2017): 99.92
(Figures in U.S. Dollars)
1 Week -1.8%   13 Weeks -13.1%  
4 Weeks -6.0%   52 Weeks 20.0%  
 
GW Pharmaceuticals PLC- ADR Key Data:
  Ticker: GWPH Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 14,570,660
(Year Ending Jan 2017).
Employees: 496
  Currency: U.S. Dollars Market Cap: 2,518,466,947
  Fiscal Yr Ends: September Shares Outstanding: 25,204,833
  Share Type: Common Closely Held Shares: 1,780,973
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.